Drugs / UNAIR Inactivated Covid-19 Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05226429 | Feb 2022 → Apr 2023 | COVID-19 | Dr. Soetomo General Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UNAIR Inactivated Covid-19 Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05226429 ↗ |